As of Jul 25
| -0.12 / -5.04%|
The 1 analysts offering 12-month price forecasts for Rxi Pharmaceuticals Corp have a median target of 35.00, with a high estimate of 35.00 and a low estimate of 35.00. The median estimate represents a +1,448.67% increase from the last price of 2.26.
The current consensus among 1 polled investment analysts is to Buy stock in Rxi Pharmaceuticals Corp. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.